Scholar Rock Holding Corp (SRRK)
15.16
+0.20
(+1.34%)
USD |
NASDAQ |
May 02, 11:37
Scholar Rock Cash from Operations (TTM): -145.23M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -145.23M |
| September 30, 2023 | -136.78M |
| June 30, 2023 | -130.99M |
| March 31, 2023 | -133.18M |
| December 31, 2022 | -132.69M |
| September 30, 2022 | -136.24M |
| June 30, 2022 | -145.74M |
| March 31, 2022 | -142.81M |
| December 31, 2021 | -126.79M |
| September 30, 2021 | -114.02M |
| June 30, 2021 | -101.44M |
| March 31, 2021 | -89.45M |
| December 31, 2020 | -60.27M |
| Date | Value |
|---|---|
| September 30, 2020 | -56.65M |
| June 30, 2020 | -48.37M |
| March 31, 2020 | -44.95M |
| December 31, 2019 | -63.12M |
| September 30, 2019 | 8.046M |
| June 30, 2019 | 14.14M |
| March 31, 2019 | 18.92M |
| December 31, 2018 | 24.57M |
| September 30, 2018 | -36.58M |
| June 30, 2018 | -33.31M |
| March 31, 2018 | -27.05M |
| December 31, 2017 | -21.74M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-145.74M
Minimum
Jun 2022
14.14M
Maximum
Jun 2019
-94.03M
Average
-114.02M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Regeneron Pharmaceuticals Inc | 4.594B |
| Ocular Therapeutix Inc | -70.23M |
| Alpine Immune Sciences Inc | -79.01M |
| Keros Therapeutics Inc | -124.51M |
| X4 Pharmaceuticals Inc | -96.51M |